This secondary analysis of data from the HERACLES-A clinical trial examines long-term outcomes in 32 patients with colorectal cancer treated with trastuzumab and lapatinib.
Central Nervous System as Possible Site of Relapse in ERBB2 -Positive Metastatic Colorectal Cancer: Long-term Results of Treatment with Trastuzumab and Lapatinib
Ciardiello F.;
2020
Abstract
This secondary analysis of data from the HERACLES-A clinical trial examines long-term outcomes in 32 patients with colorectal cancer treated with trastuzumab and lapatinib.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
